On Friday, Shares of Darling Ingredients Inc. (NYSE:DAR), surged 13.89% to $13.86.
Darling Ingredients declared financial results for the second quarter ended July 4, 2015, and that its Board of Directors approved the repurchase of up to an aggregate of $100 million of Darling’s common stock, depending on market conditions.
For the second quarter of 2015, the Company stated net sales of $859.3 million, as contrast with net sales of $1,031.3 million for the second quarter of 2014. The $172.0 million decrease in net sales is primarily attributable to lower finished product prices, primarily in the global fat markets, and by $113.9 million for the foreign exchange rate impact of a weak euro and Canadian dollar. Overall, global raw material volumes were stronger year over year.
Net income attributable to Darling for the three months ended July 4, 2015, was $3.1 million, or $0.02 per diluted share, contrast to a net income of $32.8 million, or $0.20 per diluted share, in the three months ended June 28, 2014.
Darling Ingredients Inc. develops, produces, and sells natural ingredients from edible and inedible bio-nutrients worldwide. It operates in three segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients.
Shares of Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP), inclined 9.07% to $22.13, during its last trading session.
Aquinox Pharmaceuticals declared results from secondary endpoints from its Phase 2 LEADERSHIP trial with AQX-1125 in patients with bladder pain syndrome/interstitial cystitis (BPS/IC). Aquinox also offered a general business update and stated financial results for the second quarter ending June 30, 2015.
Aquinox Pharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in discovering and developing targeted therapeutics for diseases in the areas of inflammation and immuno-oncology.
Finally, MSCI Inc. (NYSE:MSCI), ended its last trade with 1.07% gain, and closed at $64.08.
MSCI declared the results of the August 2015 Quarterly Index Review for the MSCI Equity Indexes – counting the MSCI Global Standard, MSCI Global Small Cap and MSCI Micro Cap Indexes, the MSCI Global Value and Growth Indexes, the MSCI Frontier Markets and MSCI Frontier Markets Small Cap Indexes, the MSCI Frontier Emerging Markets Index, the MSCI Global Islamic and MSCI Global Islamic Small Cap Indexes, the MSCI Pan‐Euro and MSCI Euro Indexes, the MSCI US Equity Indexes, the MSCI US REIT Index and the MSCI China A Indexes. All changes will be implemented as of the close of August 31, 2015.
MSCI Global Standard Indexes: Fifteen securities will be added to and ten securities will be deleted from the MSCI ACWI Index. In the MSCI World Index, the three largest additions measured by full company market capitalization will be Tableau Software A (USA), St. James’s Place (UK) and Ingenico Group (France). The three largest additions to the MSCI Emerging Markets Index measured by full company market capitalization will be Hanmi Science Co (Korea), Glenmark Pharmaceuticals (India) and BGF Retail (Korea).
MSCI Global Small Cap Indexes: There will be ten additions to and 16 deletions from the MSCI ACWI Small Cap Index.
MSCI Global Investable Market Indexes: There will be two additions to and three deletions from the MSCI ACWI IMI.
MSCI Inc., together with its auxiliaries, provides investment decision support tools worldwide. Its tools comprise indexes, portfolio risk and performance analytics, and multi-asset class market risk analytics products and services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
